Pharmaceutical companies are trying to navigate emerging global guidance and regulation of AI and data, something that can be difficult given the different approaches taken in different jurisdictions, according to AstraZeneca’s director of data and AI policy, Margi Sheth.
AstraZeneca: AI Regulations ‘Tricky’ To Interpret & Navigate
The pharma industry wants regulators around the world to engage with companies and “articulate the value added” when introducing new regulations and guidance around the use of AI in drug development, AstraZeneca’s director for data and AI policy says.
